Disputes & Litigation

Three decisions this month make the same uncomfortable point — your earlier conduct becomes the evidence you later have to live with. The patent claim-drafting decision over the Bayer process confirmed that overbroad language fails post-Raising the Bar support and sufficiency tests, and that claim scope must map to what the specification actually enables. The High Court’s ruling on the honest concurrent use defence fixed honesty at first use of the mark, making brand clearance a decision point that sets your position for the mark’s life. And a quieter procedural decision confirmed that fresh acts of infringement can support fresh proceedings against a familiar opponent — a reminder that procedural clarity is leverage, not housekeeping.

Patents

The patent posts reinforce that theme from the asset side: the insufficiency and best-method failure in Orikan shows how fast a patent loses strategic value when the disclosure can’t carry the weight placed on it. Priority claims, knowledge capture and specification drafting are strategic processes — treat them as administrative tasks and the gap shows up in court.

Trade Marks & Brand Governance

Beyond first-use honesty, the brand dispute resulting in injunctions and a forced name change shows the upside of doing the groundwork: clean chains of title and procedural discipline let the successful party secure broad remedies, including trade mark cancellation and indemnity costs. Well-structured IP governance converts directly into commercial leverage.

Copyright, AI & the Price of Data

Two posts track the same fast-moving front — the value of content as AI training input. The scrutiny of Anthropic’s US$1.5B settlement reframes training-data valuation as a balance-sheet issue, making provenance, licensing posture and reserve planning board-level concerns. The EU’s move to put a licensing framework for AI training on the statute book then shifts the contest from courtroom to legislation, in the jurisdiction whose rules tend to become everyone’s — so decide whether you lead as a licensor or a licensee, document provenance, and engage the consultation while the rules are still being written.

Deals, Budget & Strategy

The strategic posts pull the month together. The Federal Budget’s R&D, ESS and CGT changes reshape how IP-intensive firms fund innovation and time their investments, forcing IP strategy to integrate with capital allocation and organisational design. And the argument that AI efficiency is not a durable advantage lands the same point from the offensive side: lasting advantage comes from combining proprietary data, patents and protected workflows into AI-native offerings competitors can’t easily replicate.

What to Watch

The through-line is clear enough to act on. Courts and regulators are pushing the decisive moment upstream — into drafting, clearance, provenance and portfolio structure — and rewarding the parties who treated those steps as strategy rather than process. Two fronts deserve attention in the months ahead. First, the post-RTB enforcement standard is tightening; audit live claim sets and specifications against the construction arguments an opponent would actually run, before a dispute forces the question. Second, the AI training-data market is being priced and legislated in real time; the organisations that can prove provenance and have decided their licensor-versus-licensee posture will negotiate from strength while others are still reacting.

The decisions of the next quarter will keep testing work done long before them. The IP Strategies that win have already been build, well ahead of when they are truly tested.

The phrase “at least one small molecule” looked innocuous on the page. In practice, it stretched the monopoly beyond what the technical contribution could justify, and no amount of expert evidence about statistical improbability could rescue it. The Court was clear: low probability of an embodiment is not the same as exclusion, and the words a patentee chooses will be given work to do.

The strategic lesson runs deeper than drafting hygiene. Nalco eventually secured its amendments on appeal — but only after years of litigation, six amendment rounds, and a Full Court willing to exercise the s 105(1A) discretion afresh. That outcome turned on disciplined conduct: timely amendments, full and frank disclosure, and a credible narrative that each iteration responded to issues as they crystallised rather than to risks long known and ignored.

For IP-intensive businesses, three patterns are worth internalising.

First, the post-RTB regime rewards claim scope that maps tightly to what the specification actually enables — aspirational breadth is now a liability, not an option.

Second, opposition and appeal strategy should include pre-built fallback claim sets, stress-tested against the construction arguments your opponent is most likely to run.

Third, the discretion to amend remains genuinely available where the patentee behaves transparently — but culpable delay, tactical obscurity, or knowingly maintaining overbroad claims will close that door.

The patent bargain is being enforced more strictly than it once was; the businesses that treat claim drafting as a strategic exercise — not a downstream task — will be the ones still holding their monopolies when challenges come.

Read the full judgment here.

The strategic lesson is sharper than it first appears. Brand clearance is not a formality to be tidied up after launch — it is a decision point that fixes your legal position for the life of the mark. An adverse examination report is not noise; it is the moment your risk profile changes, and how you respond becomes part of the evidentiary record you may one day need to rely on. Ignore it, or pivot to attacking the incumbent’s registration instead of engaging with the problem, and you signal awareness of the very impediment you later have to disprove.

For founders and in-house counsel, the discipline is simple: clear the name before you commit, document the genuine basis for believing there is no conflict, and treat regulator warnings as live strategic intelligence rather than paperwork. The businesses that scale safely are the ones that get the IP groundwork right at the starting line — because that is exactly where the law will look.

The full decision, Zip Co Limited v Firstmac Limited [2026] HCA 16, is worth reading: https://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/HCA/2026/16.html

The contest between content owners and AI developers is shifting out of the courtroom and into the statute book, in the jurisdiction whose rules tend to become everyone’s rules. The question is no longer whether training data carries a price. It is who sets it, and who captures the value.

For IP-intensive organisations, this is a window, not merely a warning. The businesses that come out ahead will not be the ones waiting for a final text; they will be the ones already treating data provenance, rights reservations and licensing posture as strategic assets.

Three moves are worth considering now.

First, know your position — most companies are at once a licensor of content and a licensee of training data, and those roles pull in opposite directions; decide which one drives more value for you, and act on it.

Second, document provenance and reservations rigorously, because in a licensing market that is forming rather than formed, clean records are leverage.

Third, engage the consultation — rules under construction can still be shaped, and silence cedes that ground to competitors who show up.

The deeper lesson is one IP strategists keep relearning: regulatory uncertainty is not a reason to wait. It is precisely the moment disciplined IP strategy earns its keep, turning a looming compliance cost into a defensible competitive position. When the rules of the game are being rewritten, the smart players help hold the pen.

Sources

• European Commission, Commission seeks views on the review of EU copyright rules (18 May 2026): https://digital-strategy.ec.europa.eu/en/news/commission-seeks-views-review-eu-copyright-rules
• European Commission call for evidence portal, A better copyright environment for European creativity and innovation: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/18173-Targeted-initiative-for-a-better-copyright-environment-for-European-creativity-and-innovation-_en
• IPWatchdog, Other Barks & Bites (22 May 2026): https://ipwatchdog.com/2026/05/22/bites-barks-eu-call-for-evidence-targets-generative-ais-impact-copyright/
• Jones Day, Navigating Copyright in the Age of Generative AI: EU, French and UK Developments: https://www.jonesday.com/en/insights/2026/05/navigating-copyright-in-the-age-of-generative-ai-eu-french-and-uk-developments-and-approaches

The judgment also highlights the competitive implications of disciplined IP governance. Questions around what was disclosed, how clearly it was disclosed, and whether the best method was actually described all point to the same strategic truth: IP strength is built long before litigation. Organisations that treat priority claims, internal knowledge capture and specification drafting as strategic processes — not administrative tasks — are better positioned to defend market share and shape competitive dynamics. The lesson is straightforward: thoughtful, well‑structured IP strategy is a commercial capability, and cases like this show what happens when that capability isn’t fully developed.

Read the full judgment here: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2026/2026fca0407

More than ever, your IP strategy must now be tightly integrated with capital allocation, tax planning and organisational design.

The opportunity is to treat these changes as a catalyst for disciplined portfolio thinking. The new R&D settings reward firms that can demonstrate genuine core R&D, maintain clean evidence trails, and scale early‑stage innovation with intent. The ESS and CGT adjustments require a fresh look at how equity participation supports long‑term value creation. And the loss carry‑back and refundability rules reinforce the importance of timing — when you invest, when you recognise value, and when you lock in tax positions.

For IP‑intensive organisations, this Budget is a reminder that competitive advantage increasingly depends on the quality of your underlying systems: how you capture knowledge, how you structure incentives, and how you convert protected ideas into durable commercial outcomes.

Read PWC’s insightful article that inspired this post here.

For IP‑intensive organisations, that “valuation problem” isn’t academic. Boards should read it as a warning that data provenance, licensing posture, and reserve planning are becoming first‑order balance sheet issues.

If your business builds AI models, your defensible position will increasingly come from disciplined rights management—clean acquisition, documented permissions, and a clear story on what was used, when, and under what authority.

If your business owns content, this moment strengthens your negotiating leverage: it reinforces that “everyone’s data” arguments are weakening in the face of settlement economics, and that sophisticated rights holders will push for pricing that reflects commercial contribution, not just item counts. IP strategy is moving upstream—into product design, data governance, and deal architecture.

Audit your input rights now, model your litigation/settlement exposure as a realistic cost, and build licensing pathways that scale—because the organisations that can prove provenance will ship faster, partner easier, and carry less downside when the next dispute lands.

Read more here:

• Reuters via AOL: US judge considers Anthropic’s $1.5B settlement
• Ars Technica: Judge delays approval amid objections/fees concerns
• Courthouse News: Settlement nears approval; structure and payouts
• Authors Alliance: Fairness hearing observations and key objections

For IP‑rich businesses, the practical takeaway is clear: treat AI as a catalyst for expanding and defending profit pools, not just for internal efficiency. The winners will be those who combine protected technology, proprietary data, and defensible business models into reinforcing moats that deepen with use. As McKinsey notes, “advantage accrues disproportionately to organizations that move early, learn faster than peers, and build capabilities that compound.” That’s key to your IP strategy—identify where AI amplifies your unique assets, redesign your offerings around them, and position yourself where value will concentrate as transaction costs fall. In an AI‑reshaped economy, your IP isn’t just protection—it’s leverage.

For IP‑intensive organisations, this case illustrates how well‑structured IP governance translates directly into commercial leverage. Deakin’s ability to demonstrate ownership, reputation and goodwill — and to do so with procedural discipline — meant it could secure broad, future‑proofing injunctions, including restraints on using the “Blue Carbon Lab” name and logo and an order cancelling the respondent’s trade mark registration. The indemnity costs ruling reinforces another strategic lesson: thoughtful litigation strategy, including well‑timed settlement offers, can shift risk and cost exposure dramatically. The pattern is unmistakable: organisations that treat IP as a strategic asset — not an afterthought — are better positioned to control their narrative, protect their markets, and avoid expensive detours.

You can read the full judgment here: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2026/2026fca0583

For businesses managing patents or broader IP portfolios, the message is clear: fresh acts of infringement can support fresh proceedings, even against familiar opponents, so long as you’re not trying to re‑run old arguments. The Court also reinforced that broad filing bans are exceptional and usually require a vexatious litigant order—useful for companies dealing with repeated or unmeritorious challenges. In IP enforcement, procedural clarity isn’t housekeeping; it’s an important part of your strategy.